TENAX THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures
TENAX THERAPEUTICS, INC. (TENX) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures of 4.35 million shares for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-29.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures · last filed 2022-03-29
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2019-12-31 was 1.25K shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2020 was 4.35M shares, a 3505.23% increase from fiscal 2019.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2019 was 120.77K shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2012 was -6.20K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 12 month |
|---|---|---|---|
| 2020-12-31 | 4.35M shares 10-K · filed 2022-03-29 | ||
| 2019-12-31 | 1.25K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | 120.77K shares 10-K/A · filed 2021-04-16 | |
| 2019-09-30 | 119.52K shares 10-Q · filed 2019-11-14 | ||
| 2012-04-30 | -6.20K shares 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |